Robaxin and Vaginal infection - a phase IV clinical study of FDA data


Vaginal infection is found among people who take Robaxin, especially for people who are 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Robaxin and have Vaginal infection. It is created by eHealthMe based on reports of 7,534 people who have side effects when taking Robaxin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 26, 2022

7,534 people reported to have side effects when taking Robaxin.
Among them, 10 people (0.13%) have Vaginal infection.

What is Robaxin?

Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 8,361 Robaxin users for its effectiveness, alternative drugs and more.

What is Vaginal infection?

Vaginal infection is found to be associated with 1,439 drugs and 772 conditions by eHealthMe.

Number of Robaxin and Vaginal infection reports submitted per year:

Could Robaxin cause Vaginal infection?

Time on Robaxin when people have Vaginal infection *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Age of people who have Vaginal infection when taking Robaxin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 22.22 %
  • 50-59: 77.78 %
  • 60+: 0.0 %

Common drugs people take besides Robaxin *:

  1. Lyrica: 4 people, 40.00%
  2. Vioxx: 3 people, 30.00%
  3. Gilenya: 3 people, 30.00%
  4. Lotrel: 3 people, 30.00%
  5. Femara: 2 people, 20.00%
  6. Zometa: 2 people, 20.00%
  7. Vitamin D: 2 people, 20.00%
  8. Magnesium: 2 people, 20.00%
  9. Aredia: 2 people, 20.00%
  10. Lexapro: 2 people, 20.00%

Common side effects people have besides Vaginal infection *:

  1. Diarrhea: 8 people, 80.00%
  2. Dizziness: 8 people, 80.00%
  3. Fainting (loss of consciousness and postural tone): 6 people, 60.00%
  4. Pain In Extremity: 5 people, 50.00%
  5. Urinary Tract Infection: 5 people, 50.00%
  6. Nausea And Vomiting: 5 people, 50.00%
  7. Nausea (feeling of having an urge to vomit): 5 people, 50.00%
  8. Oedema Peripheral (superficial swelling): 5 people, 50.00%
  9. Intervertebral Disc Degeneration (spinal disc degeneration): 5 people, 50.00%
  10. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 5 people, 50.00%

Common conditions people have *:

  1. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 30.00%
  2. Neuralgia (pain in one or more nerves): 3 people, 30.00%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 20.00%
  4. Metastases To Bone (cancer spreads to bone): 2 people, 20.00%
  5. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 10.00%
  6. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 10.00%
  7. Osteoporosis (bones weak and more likely to break): 1 person, 10.00%
  8. Multiple Myeloma (cancer of the plasma cells): 1 person, 10.00%
  9. Gastritis (inflammation of stomach): 1 person, 10.00%
  10. Breast Cancer: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Robaxin and have Vaginal infection?

Check whether Vaginal infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Vaginal infection and when was it recovered:

Expand to all the drugs that have ingredients of methocarbamol:

Alternative drugs to, pros and cons of Robaxin:

Common Robaxin side effects:

Browse all side effects of Robaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Vaginal infection treatments and more:

COVID vaccines that are related to Vaginal infection:

Common drugs associated with Vaginal infection:

All the drugs that are associated with Vaginal infection:

Common conditions associated with Vaginal infection:

All the conditions that are associated with Vaginal infection:

How the study uses the data?

The study uses data from the FDA. It is based on methocarbamol (the active ingredients of Robaxin) and Robaxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: